Global Mice Model Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global mice model market is experiencing robust growth driven by increasing research activities in fields like pharmaceuticals, biotechnology, and life sciences. Mice models play a crucial role in preclinical research, serving as essential tools for studying human diseases, testing potential drugs, and understanding biological mechanisms. The market is witnessing significant demand for genetically modified mice models, particularly for studying specific genetic mutations and their effects on disease development and treatment response. Moreover, the rise in personalized medicine and the need for tailored treatment approaches further propel the demand for mice models with specific genetic backgrounds.

In addition to genetic modification, technological advancements such as CRISPR/Cas9 gene editing have revolutionized the creation of customized mice models, allowing researchers to develop more precise and sophisticated models for various research purposes. Furthermore, the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, fuels the demand for mice models for disease modeling and drug discovery. Pharmaceutical companies, academic institutions, and research organizations are investing significantly in mice model research to expedite the drug development process and bring innovative therapies to market.

Geographically, North America dominates the global mice model market, attributed to the presence of a large number of pharmaceutical and biotechnology companies, well-established research infrastructure, and favorable government initiatives supporting preclinical research. However, the Asia-Pacific region is witnessing rapid growth in the mice model market, driven by the expanding pharmaceutical industry, increasing research funding, and growing awareness about the benefits of mice models in drug development and personalized medicine. Overall, with the continuous advancements in genetic engineering technologies and the growing emphasis on translational research, the global mice model market is poised for further expansion in the coming years.

Global Mice Model Segment Analysis

In this report, the Global Mice Model Market has been segmented by animal model market Type, Mouse Type and Geography.

Global Mice Model Market, Segmentation by Type

The Global Mice Model Market has been segmented by Type into Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice and Spontaneous Mutant Mice.

The global mice model market is witnessing significant growth, primarily driven by advancements in biomedical research and the increasing demand for personalized medicine. The market is segmented by type into several categories, each serving distinct purposes in scientific experimentation and drug development.

Inbred mice represent a crucial segment, offering genetically homogeneous populations ideal for studying the effects of environmental factors and genetic variations on disease susceptibility and treatment response. Outbred mice, on the other hand, provide genetic diversity resembling human populations, enabling researchers to assess drug efficacy and safety across different genetic backgrounds.

Genetically engineered mice have garnered substantial attention due to their ability to mimic human diseases by introducing specific genetic mutations or modifications. These models serve as invaluable tools for understanding disease mechanisms and developing targeted therapies.

Hybrid/Congenic mice are bred to combine specific traits from different strains, offering researchers greater control over genetic backgrounds and phenotypic characteristics. Conditioned/surgically modified mice undergo surgical procedures or environmental manipulations to induce specific disease phenotypes, allowing researchers to study disease progression and treatment interventions.

Finally, spontaneous mutant mice arise from naturally occurring genetic mutations, providing insights into the underlying genetic causes of various diseases and facilitating the discovery of novel therapeutic targets.

The diverse range of mice models available in the market caters to the multifaceted needs of biomedical research, driving innovation and advancements in healthcare delivery. As researchers continue to uncover the complexities of human diseases, the demand for specialized mice models is expected to further propel market growth in the coming years.

Global Mice Model Market, Segmentation by Mouse Type

The Global Mice Model Market has been segmented by Mouse Type into Cages, Feed, Bedding and Other Care Products.

The global mice model market continues to witness significant growth, driven by advancements in biomedical research, pharmaceutical development, and increasing demand for personalized medicine. This market is segmented based on mouse types, including cages, feed, bedding, and other care products, each playing a crucial role in maintaining the health and well-being of research mice.

Cages represent a fundamental segment within the mice model market, providing controlled environments for housing and studying mice. These cages are designed to meet specific research requirements, such as environmental control, ease of cleaning, and compatibility with various experimental setups. Additionally, advancements in cage design have led to improved animal welfare and research outcomes.

Feed is another essential segment, as the nutritional needs of research mice are critical for maintaining their health and ensuring reliable research results. Tailored diets, enriched with essential nutrients and supplements, are formulated to meet the unique requirements of different mouse strains and research objectives. As researchers delve deeper into the molecular mechanisms of diseases, customized diets are increasingly sought after for modeling specific metabolic conditions.

Bedding plays a crucial role in providing comfort, hygiene, and environmental enrichment for research mice. High-quality bedding materials help minimize stress levels, reduce the risk of infections, and create a more naturalistic environment conducive to behavioral studies. Furthermore, bedding materials are chosen based on factors such as absorbency, dust levels, and ease of handling, ensuring optimal conditions for mouse welfare and research outcomes.

Other care products encompass a wide range of accessories and consumables essential for maintaining mice health and supporting experimental procedures. This segment includes items such as water bottles, nesting materials, enrichment toys, and cleaning agents, all of which contribute to the overall well-being and research integrity of laboratory mice. With growing emphasis on animal welfare and reproducibility, the demand for high-quality care products is expected to drive further innovation and expansion in the global mice model market.

Global Mice Model Market, Segmentation by Geography

In this report, the Global Mice Model Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Mice Model Market Share (%), by Geographical Region, 2024

The global mice model market has witnessed significant growth in recent years, fueled by the increasing demand for mice models in biomedical research across various geographies. North America holds the largest share of the market, attributed to the presence of leading pharmaceutical and biotechnology companies, well-established research infrastructure, and favorable government initiatives supporting preclinical research. Moreover, the rising prevalence of chronic diseases and the growing focus on personalized medicine have further propelled the demand for mice models in this region.

Europe follows North America in terms of market share, driven by robust investments in biomedical research, advancements in genetic engineering technologies, and the presence of prominent academic and research institutions. The Asia Pacific region is emerging as a lucrative market for mice models, owing to the expanding biopharmaceutical sector, increasing R&D activities, and rising investments in life sciences research. Countries like China, Japan, and India are witnessing rapid growth in this market due to supportive government policies and a growing focus on drug discovery and development.

In the Middle East and Africa region, the market for mice models is witnessing steady growth, primarily driven by increasing collaborations between research institutions and pharmaceutical companies, as well as rising investments in healthcare infrastructure. Latin America also presents opportunities for market growth, supported by expanding pharmaceutical and biotechnology sectors, rising investments in research and development, and increasing awareness about the benefits of using mice models in preclinical studies. Overall, the global mice model market is expected to continue its growth trajectory, driven by ongoing advancements in biomedical research and the increasing need for innovative therapies to address various diseases.

This report provides an in depth analysis of various factors that impact the dynamics of Global Mice Model Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Increasing biomedical research demand
• Technological advancements enhancing precision
• Growing prevalence of chronic diseases
• Rising focus on personalized medicine

• Expanded application in drug development: The global mice model market has witnessed substantial expansion, particularly in drug development. Mice models play a pivotal role in preclinical research, offering a cost-effective and efficient means to study human diseases and evaluate potential therapeutic interventions. With advancements in genetic engineering techniques like CRISPR-Cas9, scientists can now create mice models that accurately mimic human diseases, enabling more precise investigations into drug efficacy and safety. Additionally, the availability of diverse strains of mice allows researchers to model a wide range of human conditions, from cancer and cardiovascular diseases to neurological disorders.

  The mice model market's growth is propelled by the increasing demand for personalized medicine and targeted therapies. Mice models help researchers understand the underlying mechanisms of diseases at a molecular level, facilitating the development of tailored treatments that are more effective and have fewer adverse effects. Collaborations between academic institutions, pharmaceutical companies, and contract research organizations further drive innovation in this field, leading to the development of novel mouse models that better reflect human biology. As the pharmaceutical industry continues to prioritize precision medicine approaches, the demand for sophisticated mice models equipped with advanced technologies is expected to soar, fueling the expansion of the global mice model market in drug development.

Restraints

• Ethical concerns and regulations
• High costs of maintenance
• Complexities in genetic manipulation
• Limited availability of skilled professionals

• Variability in experimental outcomes: The global mice model market is marked by significant variability in experimental outcomes, owing to several factors including genetic diversity, environmental conditions, and methodological differences across research laboratories. Mice models are extensively used in biomedical research to study human diseases, evaluate therapeutic interventions, and understand basic biological mechanisms. However, the inherent genetic variability among mouse strains can lead to diverse responses to experimental manipulations, posing challenges for reproducibility and translatability of findings. Moreover, variations in housing conditions, diet, and handling procedures can further influence experimental outcomes, underscoring the importance of standardization and rigorous experimental design in preclinical research involving mice models.

  Despite these challenges, the global mice model market continues to witness steady growth, driven by increasing demand for personalized medicine, advancements in genetic engineering technologies, and rising investments in biomedical research. Innovative approaches such as the development of humanized mouse models, which incorporate human genes, tissues, or immune cells, hold promise for better recapitulating human disease physiology and drug responses. Additionally, efforts to enhance the reproducibility of preclinical studies through initiatives like the ARRIVE guidelines and open science practices are expected to contribute to the reliability and validity of experimental findings in the mice model market. As researchers strive to overcome variability and improve the predictive value of preclinical studies, the mice model market is poised for further expansion in the coming years.

Opportunities

• Emerging economies' adoption
• Development of novel disease models
• Collaborative research initiatives
• Advancements in CRISPR technology

• Expansion of preclinical studies: The global mice model market has experienced significant expansion, driven by the burgeoning demand for preclinical studies across various sectors such as pharmaceuticals, biotechnology, and academic research. Mice models are indispensable tools in preclinical research, offering valuable insights into human biology, disease mechanisms, and potential therapeutic interventions. With advancements in genetic engineering technologies, researchers can create highly specialized mouse models that closely mimic human diseases, allowing for more accurate preclinical testing of novel drugs and therapies. This has led to a surge in the adoption of mice models in drug discovery and development, propelling the growth of the global market.

  Increasing investment in biomedical research, rising prevalence of chronic diseases, and growing focus on personalized medicine have further fueled the demand for mice models globally. These models play a crucial role in elucidating disease pathways, evaluating drug efficacy and safety, and predicting human responses to treatments, thereby accelerating the drug development process. Additionally, collaborations between academic institutions, research organizations, and pharmaceutical companies for the development and utilization of mice models have contributed to the expansion of the market. As the importance of preclinical research continues to grow, the global mice model market is poised for sustained growth in the coming years.

Key players in Global Mice Model Market include:

• Charles River Laboratories International, Inc.
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• ENVIGO
• Laboratory Corporation of America Holdings
• Janvier Labs
• Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
• Trans Genic, Inc.
• Genoway
• Horizon Discovery Group PLC (Sage Labs, Inc.)
• Ingenious Targeting Laboratory

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis